137 related articles for article (PubMed ID: 4150441)
1. The role of the colon in the metabolism of salicylazosulphapyridine.
Das KM; Eastwood MA; McManus JP; Sircus W
Scand J Gastroenterol; 1974; 9(2):137-41. PubMed ID: 4150441
[No Abstract] [Full Text] [Related]
2. [Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)].
Eitner K; Hippius M; Reinicke C
Dtsch Z Verdau Stoffwechselkr; 1982; 42(1):14-9. PubMed ID: 6122556
[TBL] [Abstract][Full Text] [Related]
3. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.
Das KM; Eastwood MA; McManus JP; Sircus W
N Engl J Med; 1973 Sep; 289(10):491-5. PubMed ID: 4146729
[No Abstract] [Full Text] [Related]
4. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
Feurle GE; Helmstädter V
Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
[No Abstract] [Full Text] [Related]
5. Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine.
Fischer C; Maier K; Klotz U
J Chromatogr; 1981 Oct; 225(2):498-503. PubMed ID: 6117565
[No Abstract] [Full Text] [Related]
6. Sulphasalazine in inflammatory bowel disease: recent advances.
Cooper BT
N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
[No Abstract] [Full Text] [Related]
7. The effect of salazopyrin on water and electrolyte transport in the human colon measured in vivo and in vitro.
Harris J; Archampong EQ; Clark CG
Gut; 1972 Oct; 13(10):855. PubMed ID: 4404481
[No Abstract] [Full Text] [Related]
8. [Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].
Eitner K; Reinicke C; Hippius M
Dtsch Z Verdau Stoffwechselkr; 1984; 44(6):282-8. PubMed ID: 6151895
[TBL] [Abstract][Full Text] [Related]
9. [40 years of salazosulfapyridine. Is end in sight?].
van Hees PA; van Tongeren JH
Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2014-8. PubMed ID: 6129576
[No Abstract] [Full Text] [Related]
10. [Colitis--newer aspects upon ulcerative colitis and Crohn's disease in the colon].
Lakartidningen; 1973 Sep; 70(36):3051-71. PubMed ID: 4151353
[No Abstract] [Full Text] [Related]
11. [Treatment of ulcerative colitis].
Spîrchez T
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(3):189-200. PubMed ID: 767
[No Abstract] [Full Text] [Related]
12. [Pulmonary diffusing capacity disorder in nonspecific intestinal inflammations unexplainable by acetylation phenotype or treatment with sulfasalazine].
Bures J; Horácek J; Tilser P; Fixa B; Komárková O; Tichý M; Zaydlar K; Král B
Cas Lek Cesk; 1986 Jul; 125(29):905-9. PubMed ID: 2873894
[No Abstract] [Full Text] [Related]
13. Crohn's disease of the colon.
Gastroenterology; 1979 Mar; 76(3):607-21. PubMed ID: 34556
[No Abstract] [Full Text] [Related]
14. [Ulcerative colitis and Crohn disease. Early diagnosis and therapy].
Wienbeck M; Purrmann J; Miller B
Internist (Berl); 1986 Mar; 27(3):166-71. PubMed ID: 2872183
[No Abstract] [Full Text] [Related]
15. Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital.
Schröder H; Lewkonia RM; Price Evans DA
Clin Pharmacol Ther; 1973; 14(5):802-9. PubMed ID: 4147120
[No Abstract] [Full Text] [Related]
16. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
Rubinstein BE
Ugeskr Laeger; 1982 Feb; 144(5):304-6. PubMed ID: 6122297
[No Abstract] [Full Text] [Related]
17. [Possible mechanism of action of Azulfidine/Salazopyrin].
Campbell DE
Z Gastroenterol Verh; 1981 Jun; 19():15-20. PubMed ID: 6168126
[No Abstract] [Full Text] [Related]
18. Letter: Salicylazosulfapyridine in clinical practice.
Daz KM
Gastroenterology; 1974 Feb; 66(2):326. PubMed ID: 4149356
[No Abstract] [Full Text] [Related]
19. Will there be a next generation of sulfasalazine?
Goldman P
Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420
[No Abstract] [Full Text] [Related]
20. Jejunal absorption of water and electrolytes in inflammatory bowel disease.
Binder HJ; Ptak T
J Lab Clin Med; 1970 Dec; 76(6):915-24. PubMed ID: 5485380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
